Mark Donohue is Senior Director, Investor Relations and Corporate Communications for Impax Laboratories, a specialty pharmaceuticals company that develops both brand and generic products. Mr. Donohue joined Impax in April of 2008 and has led the effort to restore investor confidence and positively promote the company following security delisting and financial reporting issues.

Prior to joining the Company, he had been director of investor relations for Dow Jones & Co., a global publisher of business and financial news and information. He was responsible for developing and executing a global investor relations program.

Prior to joining Dow Jones in early 2001, he was vice president, investor relations, with Summit Bancorp, the 25th largest U.S. regional bank before its merger with FleetBoston. Before getting his start in the investor relations field in early 1999, he worked in corporate finance at Covance, Inc., after beginning his career as an auditor with Ernst & Young.

Mr. Donohue earned a bachelor’s degree in accounting from Villanova University and is a licensed Certified Public Accountant in Pennsylvania. He also served four years active duty in the United States Air Force as an air traffic controller. He currently serves on the NIRI IR Update Magazine Editorial Advisory Board and on the NIRI Philadelphia Chapter Advisory Board. He previously served on the board of the Philadelphia Chapter from 2006 to 2010, and was the Chapter’s President from 2008 to 2010. Mr. Donohue was also NIRI’s 2010 University of Michigan Theory and Practice of IR Program Scholarship recipient.

David Olson was most recently senior vice president, Corporate Communications and an executive officer of Health Net, Inc., one of the nation’s largest publicly traded managed health care companies. Mr. Olson has broad experience ranging from investors relations to crisis and financial communications with an especially deep expertise in the health care sector.

At Health Net, Mr. Olson was responsible for the company's investor relations function and internal and external communications, and also oversaw government relations and charitable contributions. He was previously vice president, Investor and Public Relations, for Health Systems International, Inc. (HSI), one of Health Net’s predecessor companies. Prior to joining HSI in 1994, he was vice president, Corporate Communications for National Medical Enterprises, Inc. (NME), having joined NME in 1989 as director of Shareholder Communications.

Previously he was a vice president with a leading investor relations firm, and served more than five years with FCS Laboratories, Inc., as director of Corporate Communications and Investor Relations.

He began his career in New York with Carl Byoir and Associates, the J. Walter Thompson Company and Burson Marsteller.

Mr. Olson is a member of the National Investor Relations Institute (NIRI) Senior Roundtable and has served on the NIRI Board of Directors. He serves on the Board of Trustees for Rolling Hills Preparatory School and the Board of the Children’s Burn Foundation. Mr. Olson holds a B.A. in English from Washington and Lee University.